New combo aims to tame breast cancer and blood sugar spikes
Disease control
Recruiting now
This study tests a new drug, evexomostat, added to two standard treatments for a common type of advanced breast cancer (HR+, HER2-). The goal is to see if the combination is safe and can reduce severe blood sugar spikes caused by the standard drugs. About 52 adults with specific …
Phase: PHASE1, PHASE2 • Sponsor: SynDevRx, Inc. • Aim: Disease control
Last updated May 17, 2026 02:00 UTC